Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial

Schumacher, H. RALPH, Becker, Michael A., Wortmann, Robert L., MacDonald, Patricia A., Hunt, Barbara, Streit, Janet, Lademacher, Christopher, Joseph‐Ridge, Nancy·2008·Arthritis Care & Research
DOI 10.1002/art.24209

Cited by (641)

Items 501–600 of 641

  1. Treat to target in gouty arthritis
    Karel Pavelká · 2018 · Vnitřní lékařství
  2. The ‘FebBenz’ approach for severe difficult-to-treat gout
    Enrique Calvo-Aranda, Claudia María Gómez-González, Fernando Pérez-Ruiz, Marta Novella-Navarro · 2025 · Exploration of Musculoskeletal Diseases
  3. Elucidating the therapeutic mechanism of Orthosiphon aristatus in hyperuricemic nephropathy: An integrated microbiome-metabolomics approach
    Haohao Quan, Jianting Ouyang, Xinwen Fu, Danyao Lin, Qiaoru Wu, Delun Li, Yimeng Li, Fan Yang, Shouhai Wu, Chuang Li et al. · 2025 · Journal of Ethnopharmacology
  4. Gout in Primary Care: Clinical Overview and Case Study
    Mohamed Toufic El Hussein, Cayla Wong · 2026 · The Journal for Nurse Practitioners
  5. Febuxostat, ein neues Pharmakon zur Behandlung der Gicht
    Peter Christalla, Katrin Wittköpper, Ali El‐Armouche · 2011 · Der Kardiologe
  6. New and emerging therapies for gout
    Daria B. Crittenden, Han Na Kim, Mark C. Fisher, David S. Goldfarb, Michael H. Pillinger · 2011 · Clinical Investigation
  7. Rising Gout, Life Threatening Public Enemy
    Jung Soo Song · 2011 · Journal of Rheumatic Diseases
  8. An update on the management of hyperuricemia and gout
    Young Ok Jung · 2009 · The Korean Journal of Internal Medicine
  9. Gout and the heart: beyond comorbidities
    Mariano Andrés, Francisca Sivera, María Amparo Quintanilla, Paloma Vela, Eliseo Pascual · 2015 · International Journal of Clinical Rheumatology
  10. Gout and Other Crystalline Arthropathies
    Aryeh M. Abeles, Michael H. Pillinger · 2012 · Elsevier eBooks
  11. The management of gout and hyperuricemia
    Robert A. Terkeltaub · 2011 · Elsevier eBooks
  12. The current treatment strategy for gouty arthritis
    М. С. Петрова, M.M. Musiychuk, Mazurov Vi · 2018 · Modern Rheumatology Journal
  13. Current Pharmacological Treatments of Chronic Gout
    Naomi Schlesinger · 2018 · Elsevier eBooks
  14. Licht und Schatten der Hyperurikämie: Neuroprotektion, Komorbiditäten und Therapiestrategien
    Heiko Pohl, Florence Vallelian, Gregor Herfs · 2019 · Praxis
  15. A new step in the treatment of "king's diseases"
    Remedium, Широкова Ирина, Julia Prozherina, Remedium · 2018 · Remedium Journal about the Russian market of medicines and medical equipment
  16. Hyperuricaemia in primary care
    Petr Němec · 2020 · Medicína pro praxi
  17. ▼Febuxostat for gout
    2010 · Drug and Therapeutics Bulletin
  18. Treatment Guidelines
    Edward Roddy, Michael Doherty · 2018 · Elsevier eBooks
  19. Urate-lowering therapy and kidney function
    М. С. Елисеев · 2023 · Modern Rheumatology Journal
  20. Principles of urate-lowering therapy: eight steps to success
    Olga V. Zhelyabina, М. С. Елисеев, Aleksander M. Lila · 2023 · Modern Rheumatology Journal
  21. Prospects for prescription of urate-lowering therapy in patients with asymptomatic hyperuricemia and gout
    E. V. Panina, М. С. Елисеев · 2023 · Meditsinskiy sovet = Medical Council
  22. Effects of WN1703 on Cardiovascular Function in Chronic Hyperuricemia Rats and Myocardial Injury Mechanism Exploration in H9C2 Cells
    Xiaodan Lu, Fuyao Liu, Hongming Chen, Haojie Cai, Lei Zhang, Jing Li · 2024 · Journal of Applied Toxicology
  23. Hyperurikämie und Gicht
    Wolfgang Gröbner · 2015 · DMW - Deutsche Medizinische Wochenschrift
  24. Treatment of Gout—A new Approach
    Anil Kumar Batta · 2014 · IOSR Journal of Dental and Medical Sciences
  25. Febuxostat in the therapy of gout: from theory to practice
    E. V. Ilyinykh, С А Владимиров, М. С. Елисеев · 2017 · Modern Rheumatology Journal
  26. Colchicin zur Behandlung der Gicht
    Judith Sautner · 2018 · rheuma plus
  27. Pharmacotherapeutic management of gout in patients with cardiac disease
    Chun Wai Chan, Ying Nee Yap · 2018 · Expert Opinion on Pharmacotherapy
  28. The quality of management of patients with gout in real clinical practice
    O. V. Teplyakova, A. Sarapulova, Popov Aa · 2019 · Modern Rheumatology Journal
  29. Gout.
    Martin R Underwood · 2015 · PubMed
  30. Traitement de la goutte
    Aurélien Mary, Amélie Boursier, Michel Brazier, Patrice Fardellone · 2018 · Elsevier eBooks
  31. New Antianginal Drugs Still Not Available for Clinical Use
    Juan Luis Tamargo, Eva Delpón · 2015 · Springer eBooks
  32. The Effectiveness of Newly FDA Approved Uloric (Febuxostat) Versus the Conventionally Used Zyloprim (Allopurinol) in Treatment of Hyperuricemia and Chronic Gout in the Adult Population
    Kyle K. Ohisa · 2009 · CommonKnowledge Research Repository (Pacific University Oregon)
  33. Management of Hyperuricemia and Gout
    David S. Newcombe · 2012 · Springer eBooks
  34. Raschere Diagnose durch hausärztliche Vorarbeit
    Bernhard Rintelen · 2012 · rheuma plus
  35. The Efficacy and Safety of Febuxostat in Korean Patients with Gout
    Sung Won Lee · 2013 · Journal of Rheumatic Diseases
  36. Gota: nuevos conceptos patogénicos y nuevos agentes terapéuticos
    José Alfredo Gómez-Puerta · 2011 · Revista Colombiana de Reumatología
  37. Febuxostat: a new drug for an old disease. Do we really need it?
    Giovanni Gulli, Luigi De Filippis · 2013 · Italian Journal of Medicine
  38. Pharmacothérapie rationnelle (PTR) de la goutte : utiliser la méthode du « Treat-to-Target » et bien définir l’uricémie finale visée
    Tim Jansen · 2015 · Revue du Rhumatisme
  39. A New Standard of Care? Studies on Febuxostat in the Management of Hyperuricemia With and Without Gout
    Naoyuki Kamatani, Tatsuo Hosoya · 2011 · JCR Journal of Clinical Rheumatology
  40. Was ist neu in der Diagnostik und Therapie der Gicht?
    Monika A Reuss-Borst · 2014 · MMW - Fortschritte der Medizin
  41. Febuxostat
    Dennis J. Cada, Terri L. Levien, Danial E. Baker · 2009 · Hospital Pharmacy
  42. The Next Generation of Gout Therapeutics: Ready for Prime Time?
    Aryeh M. Abeles, Michael H. Pillinger · 2010 · Current Rheumatology Reports
  43. Febuxostat provides new gout treatment option
    Jennifer M. Belavic · 2010 · The Nurse Practitioner
  44. Management of Chronic Hyperuricemia with Febuxostat
    2011 · Clinical Medicine Reviews in Therapeutics
  45. Febuxostat treatment for gout: what the clinician needs to know
    Lan X. Chen, H. Ralph Schumacher · 2009 · Therapeutic Advances in Musculoskeletal Disease
  46. Eficacia y efectividad de los tratamientos reductores de la uricemia
    Cèsar Díaz‐Torné, Cèsar Díaz‐Torné · 2013 · Seminarios de la Fundación Española de Reumatología
  47. Uric acid - a renal and non-renal risk factor
    Eberhard Ritz · 2013 · Postępy Nauk Medycznych
  48. Kristallarthropathien
    Monika A Reuss-Borst · 2015 · Elsevier eBooks
  49. Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
    Irfan Zafar, Moosa Khan, Syed Mohsin Turab, Rafeeq Alam Khan · 2012 · DOAJ (DOAJ: Directory of Open Access Journals)
  50. Uric Acid, Allopurinol: The Cardio-Renal Silver Bullet?
    Adrian Constantin Covic, Luminita E. Voroneanu · 2014 · Springer eBooks
  51. Étude descriptive de la prise en charge de la goutte en pratique de médecine générale dans le bassin annécien
    F. Kayser · 2015 · HAL
  52. Rising a Novel Weapon in the War against Gout and Hyperuricemia
    Jung Soo Song · 2016 · Journal of Rheumatic Diseases
  53. Modifiable Barriers to Optimal Outcomes in Gout Management
    Brian W. Coburn · 2016 · DigitalCommons@UNMC
  54. THESE PRESENTEE POUR L'OBTENTION DU DOCTORAT EN MEDECINE DIPLÔME D'ETAT
    F. Kayser · 2015
  55. Onderhoudsbehandeling bij jicht
    Kenny van Deventer, Dick Bijl · 2015 · TvPO
  56. Managing the Risks to Gain the Benefits
    Robert T. Keenan · 2012
  57. Gout and Crystal Deposition Disease
    Brian F. Mandell · 2009 · Elsevier eBooks
  58. GOUT AS AN AUTOINFLAMMATORY DISEASE: FROM CELLULAR TO GENETIC MECHANISMS
    Emma García Melchor · 2014 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  59. NEPHROLOGY & UROLOGY | RESEARCH ARTICLE Febuxostat is superior to traditional urate-lowering agents in reducing the progression of kidney function in chronic kidney disease patients
    Shuo‐Chun Weng, Der‐Cherng Tarng, Yu‐Chi Chen, Ming‐Ju Wu · 2016
  60. Polymyosite éosinophilique liée à l’utilisation du fébuxostat dans le traitement d’un lymphome de la zone marginale
    Georges Y. Chahine, Khalil Saleh, Claude Sader Ghorra, Nathalie Khoury, Nadine Khalife, Fouad Fayad · 2017 · Revue du Rhumatisme
  61. The problems associated with the treatment of chronic hyperuricaemia in Serbia
    Miloš N. Milosavljević, Milica Milosavljević · 2016 · Praxis medica
  62. Uric acid, blood pressure, and gout management
    Scheepers · 2017
  63. Effectiveness and Tolerability of Febuxostat vs Allopurinol in patients with Chronic Kidney Disease (CKD) on Conservative Therapy
    Ennio Duranti · 2017 · Archives of Renal Diseases and Management
  64. Anti-inflammatory and antipyretic analgesics and drugs used in gout
    Sebastian Straube · 2011 · Side effects of drugs annual
  65. Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres
    Pierre‐Antoine Juge, Marie‐Elise Truchetet, Évangéline Pillebout, Sébastien Ottaviani, Cecile M. Vigneau, Clotilde Loustau, Divi Cornec, Tristan Pascart, Renaud Snanoudj, F. Bailly et al. · 2017 · Revue du Rhumatisme
  66. Colchicin zur Behandlung der Gicht
    Raimund Lunzer · 2018 · rheuma plus
  67. Urate–lowering therapy: xanthine oxidase inhibitors
    Lisa K. Stamp · 2013
  68. Treat to Target
    Fernando Pérez-Ruiz, Boris Anthony Blanco Cáceres · 2018 · Elsevier eBooks
  69. Switching from Allopurinol to Febuxostat: A Comparison of The Rate of Renal Functional Decline in Patients With Moderate and Severe Chronic Kidney Disease
    Motoaki Miyazono · 2018 · Biomedical Journal of Scientific & Technical Research
  70. Gout: objective, indications and adherence to uratelowering therapy
    Vladimir Viktorovich Tsurko, T. Ye. Morozova, Margarita Aleksandrovna Gromova, K. M. Krykhivskaya · 2019 · Meditsinskiy sovet = Medical Council
  71. Urate-lowering therapy for heart failure
    Olga V. Zhelyabina, М. С. Елисеев · 2019 · Modern Rheumatology Journal
  72. PNEUMOCYSTIC PNEUMONIA IN RHEUMATIC DISEASES: CURRENT ISSUES IN PROPHYLAXIS
    М. С. Елисеев · 2017 · Meditsinskiy sovet = Medical Council
  73. Current Possibilities in the Correction of Hyperuricemia in Patients with Urolithiasis and Uric Acid Hypercrystallization
    В. В. Черненко, В. Й. Савчук, Н. І. Желтовська, Д. В. Черненко, Ю. М. Бондаренко · 2019 · Health of Man
  74. The new generation uricosuric drugs, xanthine oxidase inhibitors, and combination therapy as options for gout pharmacotherapy – a review paper
    Daniel Wiśniewski, Izabela Uzar · 2019 · Farmacja Polska
  75. The effect of allopurinol on left ventricular mass in patients with treated essential hypertension
    Christopher Gingles · 2019 · Discovery Research Portal (University of Dundee)
  76. To compare the efficacy, tolerability and patient acceptability of Allopurinol and Febuxostat in Hyperuricemic Patients.
    Tafazzul Hussain, Mohsin Turab, Musarrat Sultana, Fuad Shaikh, SYED SAUD HASAN, Shamaila Khalid · 2020 · The Professional Medical Journal
  77. Antihyperuricemic Agents
    Ted R. Mikuls · 2013 · Elsevier eBooks
  78. Pharmacokinetics of Anti-Rheumatic Drugs in a Geriatric Patient
    Lee Hilary Goldstein · 2020 · Springer eBooks
  79. Clinical discussion: gout therapy in a comorbid patient
    М. С. Елисеев, A. M. Novikova · 2020 · Meditsinskiy sovet = Medical Council
  80. Febuxostat
    Ute Eisenberger · 2011 · Der Nephrologe
  81. CHRONIC GOUT AND HYPERURICEMIA
    Faaiz Ali Shah, Haziq Dad Khan, Kifayatullah, Zulfiqar Ali Durrani, Smatullah, Zahir Khan · 2014 · The Professional Medical Journal
  82. Hyperurikämie - mehr als Gicht Auswirkung auf das kardiovaskuläre Risiko und die Niereninsuffizienz
    Lorenz K. Sellin, Jan Thomas Kielstein, Kirsten de Groot · 2015 · Zeitschrift für Rheumatologie
  83. Patient Adherence to Chronic Gout Medication
    Aki Shiozawa · 2019
  84. National consensus on diagnosis and treatment of gout
    Rada Gancheva, Pavlina Pavlova, Zlatimir Kolarov · 2020 · Rheumatology (Bulgaria)
  85. Renoprotective Effect of Febuxostat Compared with Allopurinol in Hyperuricemic Chronic Kidney Disease Patients Stage 3 and 4
    Heba Selim Elshair, Yasser A. Nienaa, Rana Koreen, Noha Mohamed Elkholy · 2022 · Medicine Updates
  86. Current World Literature
    2010 · Current Opinion in Rheumatology
  87. Available treatment options for hyperuricemic patients
    Mihai-Emil Gherghina · 2021 · Romanian Journal of Medical Practice
  88. The problems associated with the treatment of chronic hyperuricaemia in Serbia
    Milos Milosavljevic, Milica Milosavljevic · 2016 · Praxis medica
  89. Gout
    Michael T. Murray, John Nowicki · 2020 · Elsevier eBooks
  90. Treat gout with anti-inflammatories and urate-lowering therapies, unless such treatment is ineffective or inappropriate
    &NA; · 2012 · Drugs & Therapy Perspectives
  91. DRUGS USED IN THE TREATMENT OF GOUT
    2010 · Elsevier eBooks
  92. Gout
    Michael T. Murray · 2013 · Elsevier eBooks
  93. Febuxostat
    Salahuddin Ahmed, Louisa M Bethell · 2013 · Practical Diabetes
  94. Gout
    Sonia Nasi, Alexander K.-L. So · 2014 · Springer eBooks
  95. Kristallarthropathien
    Monika A Reuss-Borst · 2018 · Elsevier eBooks
  96. Omega–3 fatty acids for preventing acute attacks of gout - a feasibility study
    Abhishek Abhishek, Damini Mistry · 2019 · http://isrctn.com/
  97. New drugs: Febuxostat
    2015 · Australian Prescriber
  98. Optimizing the management of patients with gout in daily practice
    Ritch te Kampe · 2022
  99. GOUT AND HYPERURICEMIA AS ADDITIONAL FACTORS OF DETERIORATION OF CARDIAC AND RENAL PATHOLOGIES
    І.О. Снігурська, В.В. Божко, D.К. Miloslavsky, Т. Г. Старченко · 2022 · Bulletin of Problems Biology and Medicine
  100. Time To Control Gout and Make It Crystal Clear
    Karolina Windloch · 2017 · EMJ Rheumatology